Together, the constructed structure of the trimeric full-length wild-type spike protein bound with ACE2 and the key binding residues identified in this study provide new insights into understanding mechanisms of SARS-CoV-2 infection of host cells, which could facilitate the development of drugs and vaccines to prevent SARS-CoV-2 infection and to combat COVID-19. Here, ACE2 is linked to COVID-19.